title: MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.
abstract: NRP1 as multifunctional non-tyrosine-kinase receptors play critical roles in tumor progression. MicroRNAs (miRNAs) are an important class of pervasive genes that are involved in a variety of biological functions, particularly cancer. It remains unclear whether miRNAs can regulate the expression of NRP1. The goal of this study was to identify miRNAs that could inhibit the growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. We found that miR-338 expression was reduced in gastric cancer cell lines and in gastric cancer tissues. Moreover, we found that miR-338 inhibited gastric cancer cell migration, invasion, proliferation and promoted apoptosis by targeting NRP1 expression. As an upstream regulator of NRP1, miR-338 directly targets NRP1. The forced expression of miR-338 inhibited the phosphorylation of Erk1/2, P38 MAPK and Akt; however, the expression of phosphorylated Erk1/2, P38 MAPK and Akt was restored by the overexpression of NRP1. In AGS cells infected with miR-338 or transfected with SiNRP1, the protein levels of fibronectin, vimentin, N-cadherin and SNAIL were decreased, but the expression of E-cadherin was increased. The expression of mesenchymal markers in miR-338-expressing cells was restored to normal levels by the restoration of NRP1 expression. In vivo, miR-338 also decreased tumor growth and suppressed D-MVA by targeting NRP1. Therefore, we conclude that miR-338 acts as a novel tumor suppressor gene in gastric cancer. miR-338 can decrease migratory, invasive, proliferative and apoptotic behaviors, as well as gastric cancer EMT, by attenuating the expression of NRP1.
authors.affiliation: Department of Gastroenterology and Hepatology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Yang
authors.initials: Y
authors.lastname: Peng
authors.affiliation: Department of Gastroenterology and Hepatology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Yan-Min
authors.initials: YM
authors.lastname: Liu
authors.affiliation: Department of Gastroenterology and Hepatology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Lu-Chun
authors.initials: LC
authors.lastname: Li
authors.affiliation: Department of Gastroenterology and Hepatology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Lu-Lu
authors.initials: LL
authors.lastname: Wang
authors.affiliation: Department of Gastroenterology and Hepatology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Xiao-Ling
authors.initials: XL
authors.lastname: Wu
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001483:Base Sequence; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics*; D049109:Cell Proliferation; D015536:Down-Regulation / Q000235:genetics; D004848:Epithelium / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D006801:Humans; D008297:Male; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D055806:Microvessels / Q000378:metabolism; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D039942:Neuropilin-1 / Q000235:genetics*; D010641:Phenotype; D015398:Signal Transduction / Q000235:genetics; D013274:Stomach Neoplasms / Q000098:blood supply / Q000235:genetics* / Q000473:pathology*
chemical_list: C532050:MIRN338 microRNA, human; D035683:MicroRNAs; D039942:Neuropilin-1
references.citation: Genes Dev. 2006 Aug 15;20(16):2202-7
references.pmid: 16882971
references.citation: J Biol Chem. 1996 Mar 8;271(10):5761-7
references.pmid: 8621443
references.citation: J Cell Biochem. 2003 Mar 1;88(4):744-57
references.pmid: 12577308
references.citation: Cell. 1997 Aug 22;90(4):739-51
references.pmid: 9288753
references.citation: APMIS. 2004 Apr-May;112(4-5):257-63
references.pmid: 15233640
references.citation: Blood. 2005 Mar 1;105(5):1992-9
references.pmid: 15522955
references.citation: J Biol Chem. 2000 Jun 16;275(24):18040-5
references.pmid: 10748121
references.citation: Int J Oncol. 2013 Jul;43(1):297-306
references.pmid: 23685409
references.citation: Biochem J. 2011 May 1;435(3):609-18
references.pmid: 21306301
references.citation: Genes Dev. 2006 Mar 1;20(5):515-24
references.pmid: 16510870
references.citation: Angiogenesis. 2014 Jan;17(1):247-60
references.pmid: 24114198
references.citation: Cell Cycle. 2010 Jun 15;9(12):2363-74
references.pmid: 20519943
references.citation: Nat Cell Biol. 2008 May;10(5):593-601
references.pmid: 18376396
references.citation: J Biol Chem. 2003 Dec 5;278(49):48848-60
references.pmid: 14514674
references.citation: Br J Cancer. 2003 Mar 10;88(5):796-802
references.pmid: 12618892
references.citation: Histopathology. 2013 May;62(6):908-15
references.pmid: 23551578
references.citation: J Pathol. 2011 Nov;225(3):463-72
references.pmid: 21671467
references.citation: Cell. 1998 Mar 20;92(6):735-45
references.pmid: 9529250
references.citation: Circ Res. 2008 Sep 12;103(6):e71-9
references.pmid: 18723443
references.citation: Trends Cell Biol. 2007 Mar;17(3):118-26
references.pmid: 17197185
references.citation: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1292-6
references.pmid: 21129279
references.citation: Mol Cancer. 2010 Oct 15;9:276
references.pmid: 20950431
references.citation: Br J Cancer. 2005 Jul 25;93(2):233-41
references.pmid: 15956974
references.citation: Nat Cell Biol. 2010 Mar;12(3):247-56
references.pmid: 20173740
references.citation: Nat Rev Mol Cell Biol. 2007 Jan;8(1):23-36
references.pmid: 17183358
references.citation: Cancer Genet. 2011 Sep;204(9):486-91
references.pmid: 22018270
references.citation: Nature. 2005 Jun 9;435(7043):834-8
references.pmid: 15944708
references.citation: Carcinogenesis. 2011 Apr;32(4):613-21
references.pmid: 21186301
references.citation: J Cell Biol. 2004 May 10;165(3):371-81
references.pmid: 15138291
references.citation: Clin Cancer Res. 2008 Dec 15;14(24):8052-60
references.pmid: 19088020
references.citation: J Invest Dermatol. 2010 Aug;130(8):2062-70
references.pmid: 20357817